The Cell Culture Dish
This week’s biotechnology news headlines include, gene tests identify breast cancer patients who can skip chemotherapy study says, Pfizer boosts cancer drug roster with $14 billion Medivation deal, Eli Lilly and Astra Zeneca get Fast Track status...
This past June Cell Culture Dish attended the International Society for Stem Cell Research (ISSCR) Annual Meeting in San Francisco and over the next several weeks we will be sharing information that we gathered. One topic that I was happy to see...
Scientists report that a specialized drug screen test using lab-grown human cells has revealed two classes of compounds already in the pharmaceutical arsenal that may work against mosquito-borne Zika virus infections.
Scientists have developed an artificial metalloenzyme that catalyses a reaction inside of cells without equivalent in nature. This could be a prime example for creating new non-natural metabolic pathways inside living cells.
Thanks, Tim, for bringing the wonder back into science for me again!"
Momenta Pharmaceuticals, Inc.